NCT05309915View on ClinicalTrials.gov

A Study of STP707 Administered by IV in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions

Healthy Subjects

Interventions

DRUG

STP707

STP707 Powder for Injection, contains 2 (siRNA) and (HKP+H) delivery system.

Trial Locations (1)

45227

Medpace, Cincinnati

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Medpace, Inc.

INDUSTRY

lead

Sirnaomics

INDUSTRY

NCT05309915 - A Study of STP707 Administered by IV in Healthy Subjects | Biotech Hunter | Biotech Hunter